| mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
8e-10 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-09 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.29 |
9e-08 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |